Six-year recurrence free survival after intraluminal iridium-192 therapy of human bilobar biliary papillomatosis - A case report

Citation
P. Gunven et al., Six-year recurrence free survival after intraluminal iridium-192 therapy of human bilobar biliary papillomatosis - A case report, CANCER, 89(1), 2000, pp. 69-73
Citations number
15
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER
ISSN journal
0008543X → ACNP
Volume
89
Issue
1
Year of publication
2000
Pages
69 - 73
Database
ISI
SICI code
0008-543X(20000701)89:1<69:SRFSAI>2.0.ZU;2-T
Abstract
BACKGROUND. Biliary papillomatosis is rare and often fatal. Liver resection or transplantation is recommended but may be impossible due to tumor or pa tient factors; furthermore, it appears to the authors of this study that no follow-up results after transplantation have been reported in previous stu dies. METHODS. Bilobar but limited biliary papillomatosis in a man age 54 years w as mapped by cholangiopancreatography, cholecystectomy, and operative chola ngioscopy. After cholangioscopic electrocoagulation, iridium-192 wires were temporarily inserted into the affected bile ducts, giving a dose of 60 gra ys at a 3-mm distance. Another percutaneous cholangioscopic electrocoagulat ion was performed 3 weeks later. RESULTS. The patient has been free of tumor and in good health for 80 month s, but he has a long term stenting of a nonneoplastic stricture at the conf luence of the bile ducts. CONCLUSIONS. Mechanical tumor reduction and intraluminal brachytherapy coul d possibly replace transplantation (which up to now has been suggested but not reported) when this life-threatening disease is bilobar, and also possi bly replace liver resection for limited tumors in patients who are too frai l for surgery. (C) 2000 American Cancer Society.